Ottimo Pharma

Private · United Kingdom

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Phase 1/2
Next date
OTP-01, Phase 1/2 trial completes
Drugs
1
in active trials
Trials
1 active
1 since 2021

Drugs1

DrugHow it worksPartnerStageNext dateDetails
PD-1/VEGFR2 bifunctional antibody
Phase 1/2 Dec 2028Phase 1/2 trial completes

About

SEC filings
None: Ottimo Pharma is private
Sources
ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021 · Logos provided by Logo.dev

Follow Ottimo Pharma

Following is part of Solo: you see every change to Ottimo Pharma the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in